米托蒽醌治疗恶性黑色素瘤
Mitoxantrone in malignant melanoma.
作者信息
Presant C A, Gams R, Bartolucci A
出版信息
Cancer Treat Rep. 1984 Jun;68(6):903-5.
PMID:6733704
Abstract
Twenty-nine patients with metastatic malignant melanoma without prior chemotherapy and 36 patients refractory to prior chemotherapy received mitoxantrone (5 mg/m2/week). No patient achieved a partial response. The dose-limiting toxic effect was granulocytopenia. Mitoxantrone is ineffective in malignant melanoma.
摘要
29例未经前期化疗的转移性恶性黑色素瘤患者和36例对前期化疗难治的患者接受了米托蒽醌（5毫克/平方米/周）治疗。无一例患者达到部分缓解。剂量限制性毒性作用为粒细胞减少。米托蒽醌对恶性黑色素瘤无效。
Zotero 插件